Literature DB >> 18205258

Influence of quasispecies on virological responses and disease severity in patients with chronic hepatitis C.

Deepak Kumar1, Abdul Malik, Mohammad Asim, Anita Chakravarti, Rakha-H Das, Premashis Kar.   

Abstract

AIM: To elucidate the influence of quasispecies on virological response and disease severity in patients with chronic hepatitis C.
METHODS: Forty seven patients with hepatitis C [32 with chronic active hepatitis (CAH), 9 with cirrhosis, and 6 with hepatocellular carcinoma (HCC)] were screened for the presence of quasispecies by single stranded conformational polymorphism (SSCP) analysis in the hypervariable region (HVR) and non-structural 5B (NS5B) viral genes of hepatitis C virus. The 41 patients excluding those with HCC were on therapy and followed up for a year with the determination of virological response and disease severity. Virus isolated from twenty three randomly selected patients (11 non-responders and 12 showing a sustained virological response) was sequenced for the assessment of mutations.
RESULTS: The occurrence of quasispecies was proportionately higher in patients with HCC and cirrhosis than in those with CAH, revealing a significant correlation between the molecular evolution of quasispecies and the severity of disease in patients with hepatitis C. The occurrence of complex quasispecies has a significant association (P < 0.05) with the non-responders, and leads to persistence of infection. Significant differences (P < 0.05) in viral load (log10 IU/mL) were observed among patients infected with complex quasispecies (CQS), those infected with simple quasispecies (SQS) and those with no quasispecies (NQS), after 12 wk (CQS-5.2 +/- 2.3, SQS-3.2 +/- 1.9, NQS-2.8 +/- 2.4) and 24 wk (CQS-3.9 +/- 2.2, SQS-3.0 +/- 2.2, NQS-2.1 +/- 2.3) in the HVR region. However, a statistically significant difference (P < 0.05) was observed between the viral loads of patients infected with CQS and those infected with NQS in NS5B viral gene after 24 wk (CQS-3.9 +/- 2.2, SQS-3.0 +/- 2.2, and NQS-2.1 +/- 2.3) and 48 wk (CQS-3.1 +/- 2.7, SQS-2.3 +/- 2.4, NQS-2.0 +/- 2.3) of therapy. Disease severity was significantly associated with viral load during therapy. The strains isolated from non-responders showed close pairing on phylogeny based on the NS5B gene, but dissimilar HVR regions. This revealed the possibility of the selection of resistant strains during the evolution of quasispecies in NS5B.
CONCLUSION: Viral quasispecies may be an important predictor of virological responses to combination therapy in patients with chronic hepatitis C. Complex quasispecies and resistant strains may lead to high viral loads during therapy, with a concerted effect on disease severity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18205258      PMCID: PMC2683995          DOI: 10.3748/wjg.14.701

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin.

Authors:  Isabella Abbate; Oreste Lo Iacono; Rosa Di Stefano; Giuseppina Cappiello; Enrico Girardi; Roberta Longo; Donatella Ferraro; Giorgio Antonucci; Vito Di Marco; Mariacarmela Solmone; Antonio Craxì; Giuseppe Ippolito; Maria R Capobianchi
Journal:  J Hepatol       Date:  2004-05       Impact factor: 25.083

2.  Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome.

Authors:  Patrizia Farci; Rita Strazzera; Harvey J Alter; Stefania Farci; Daniela Degioannis; Alessandra Coiana; Giovanna Peddis; Francesco Usai; Giancarlo Serra; Luchino Chessa; Giacomo Diaz; Angelo Balestrieri; Robert H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

3.  Dynamics of viral quasispecies during interferon therapy in non responder chronic hepatitis C patients.

Authors:  M A Thelu; M Baud; V Leroy; J M Seigneurin; J P Zarski
Journal:  J Clin Virol       Date:  2001-08       Impact factor: 3.168

4.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

Review 5.  Hepatitis C viral quasispecies.

Authors:  J Gómez; M Martell; J Quer; B Cabot; J I Esteban
Journal:  J Viral Hepat       Date:  1999-01       Impact factor: 3.728

6.  The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

Authors:  P Farci; A Shimoda; A Coiana; G Diaz; G Peddis; J C Melpolder; A Strazzera; D Y Chien; S J Munoz; A Balestrieri; R H Purcell; H J Alter
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

7.  Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion.

Authors:  Tomasz Laskus; Jeffrey Wilkinson; Juan F Gallegos-Orozco; Marek Radkowski; Debra M Adair; Marek Nowicki; Eva Operskalski; Zelma Buskell; Leonard B Seeff; Hugo Vargas; Jorge Rakela
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

8.  Hepatitis C virus E2 and NS5A region variability during sequential treatment with two interferon-alpha preparations.

Authors:  Emanuele Durante Mangoni; Daniel M Forton; Giuseppe Ruggiero; Peter Karayiannis
Journal:  J Med Virol       Date:  2003-05       Impact factor: 2.327

9.  Analysis of mutations within the 5' untranslated region, interferon sensitivity region, and PePHD region as a function of response to interferon therapy in hepatitis C virus-infected patients in India.

Authors:  Romi Gupta; Murugan Subramani; Mohammed N Khaja; Chandra Madhavi; Swagata Roy; Chittoor M Habibullah; Saumitra Das
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon-ribavirin therapy.

Authors:  I Vuillermoz; E Khattab; E Sablon; I Ottevaere; D Durantel; C Vieux; C Trepo; Fabien Zoulim
Journal:  J Med Virol       Date:  2004-09       Impact factor: 2.327

View more
  1 in total

1.  A Two-Level, Intramutant Spectrum Haplotype Profile of Hepatitis C Virus Revealed by Self-Organized Maps.

Authors:  Soledad Delgado; Celia Perales; Carlos García-Crespo; María Eugenia Soria; Isabel Gallego; Ana Isabel de Ávila; Brenda Martínez-González; Lucía Vázquez-Sirvent; Cecilio López-Galíndez; Federico Morán; Esteban Domingo
Journal:  Microbiol Spectr       Date:  2021-11-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.